Amisulpride is primarily used in the treatment of schizophrenia and other psychiatric disorders. It is effective in managing both positive symptoms such as hallucinations and delusions, as well as negative symptoms like social withdrawal and lack of motivation. Due to its selective action on dopamine receptors, it offers a favorable side effect profile compared to older antipsychotics, with lower risk of movement disorders. Amisulpride is also used off-label for the treatment of depression, particularly in cases with associated anxiety or retardation. Its ability to modulate dopamine activity at low doses makes it useful in addressing depressive symptoms. Additionally, it has been employed in managing nausea and vomiting in palliative care settings, although this use is less common. The compound’s pharmacokinetic properties allow for both oral and intravenous administration, enhancing its utility in acute and chronic treatment scenarios.